Chaolong Liu

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 4

Top Topics

Circulating Tumor

Top Venues

Journal of the American Chemical Society

This page only lists publications with an associated author ORCID identifier.

Publications

Dengshuai Wei, Junning Fan, Jianqin Yan, Chaolong Liu, Jie Cao, Chun Xu, Yong Sun, Haihua Xiao
Nuclear-Targeting Lipid Pt IV Prodrug Amphiphile Cooperates with siRNA for Enhanced Cancer Immunochemotherapy by Amplifying Pt-DNA Adducts and Reducing Phosphatidylserine Exposure. Journal of the American Chemical Society 146 (1) (2023)
Dengshuai Wei, Junning Fan, Jianqin Yan, Chaolong Liu, Jie Cao, Chun Xu, Yong Sun, Haihua Xiao
Nuclear-Targeting Lipid Pt IV Prodrug Amphiphile Cooperates with siRNA for Enhanced Cancer Immunochemotherapy by Amplifying Pt-DNA Adducts and Reducing Phosphatidylserine Exposure. Journal of the American Chemical Society 146 (1) (2023)
Dengshuai Wei, Junning Fan, Jianqin Yan, Chaolong Liu, Jie Cao, Chun Xu, Yong Sun, Haihua Xiao
Nuclear-Targeting Lipid Pt IV Prodrug Amphiphile Cooperates with siRNA for Enhanced Cancer Immunochemotherapy by Amplifying Pt-DNA Adducts and Reducing Phosphatidylserine Exposure. Journal of the American Chemical Society (2023)
Dengshuai Wei, Junning Fan, Jianqin Yan, Chaolong Liu, Jie Cao, Chun Xu, Yong Sun, Haihua Xiao
Nuclear-Targeting Lipid Pt IV Prodrug Amphiphile Cooperates with siRNA for Enhanced Cancer Immunochemotherapy by Amplifying Pt-DNA Adducts and Reducing Phosphatidylserine Exposure. Journal of the American Chemical Society 146 (1) (2023)